Paragon 28, Inc. (FNA)

Medical device company specializing in foot and ankle orthopedic implants and instruments.

FNA Stock Quote

Company Report

Paragon 28, Inc. specializes in the design, development, distribution, and global sales of advanced surgical systems tailored for foot and ankle procedures. The company's extensive product portfolio includes a variety of innovative plating systems such as the gorilla plating series, which encompasses solutions for lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion. Additionally, Paragon 28 offers specialized components like baby gorilla plate-specific screws, navicular fracture plates, 5th metatarsal hook plates, and silverback plating systems.

The precision guide technology developed by Paragon 28 supports a wide array of surgical procedures, including fusion techniques for addressing bunions, first tarsometatarsal arthrodesis, and metatarsal osteotomy for bunion correction. The company also provides solutions for medial column beaming in charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. Its product lineup extends to bone reconstruction and osteotomy with systems like the monster, mini monster, and joust beaming screw systems, facilitating joint fusion, ligament fixation, fracture repair, and fracture fixation.

Paragon 28 further enhances its offerings with the APEX 3D total ankle replacement systems and total talus spacers designed to replace and support the talus bone in ankle joints. The company is also recognized for its comprehensive range of bunion correction systems, including nail systems like the phantom intramedullary nail systems for severe hallux valgus conditions. Moreover, Paragon 28 supplies various orthobiologics such as bone wedges, grafts, demineralized bone matrices, and synthetic materials, alongside advanced soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments.

Operating globally, Paragon 28 serves hospitals and ambulatory surgery centers through a robust network of sales representatives and stocking distributors. Established in 2010 and headquartered in Englewood, Colorado, the company continues to innovate and expand its portfolio to meet the evolving needs of foot and ankle surgeons worldwide.

FNA EPS Chart

FNA Revenue Chart

Stock Research

NREF SHCR MBAC RIGL RKTA INDB XPL

FNA Chart

View interactive chart for FNA

FNA Profile

FNA News

Analyst Ratings